Investments in cutting-edge tooling and test center drive growth for global healthcare innovators

GERMANTOWN, Wisc. (April 25, 2024) – a global leader in healthcare end-to-end engineering and manufacturing solutions, is proud to announce the completion of significant upgrades to its Lynge, Denmark engineering facility to complete its transformation into a state-of-the-art tooling facility. The two-phased upgrades of the MGS Lynge facility, previously Winther Mould Technology A/S, began shortly following the company’s acquisition in 2023.

Transforming the Lynge facility from a traditional moldmaker into a best-in-class European toolmaker involved strategic investments in processes, equipment and technology advancements in accordance with MGS’ global tooling standards. This state-of-the-art campus features 4,000 square meters of production space dedicated to early supplier involvement (ESI), design for manufacturability (DFM), Fast-Track pilot tooling, production tool development and enhanced metrology systems.

At MGS Lynge, teams now have access to expanded machining capabilities with 5-axis laser texturing and high-speed milling as well as automated robotic handling. With the facility upgrades, the Lynge team will be able to accelerate production while maximizing capacity and ensuring exceptional quality, which is essential for the company’s Pharma, Diagnostics and MedTech customers.      

MGS President and CEO Paul Manley stated, “Through strategic acquisitions of companies like Winther Mould Technology, we are building capacity to bring advanced technologies to global innovators who require precision tooling for critical innovations that improve lives. The upgrades to this facility allow us to enhance the team’s existing capabilities and expertise while standardizing processes to facilitate collaboration across our global engineering teams.”      

The second phase of the facility upgrades will bring updates to the 3,000-square-meter Innovation and Test Center that houses first off tool (FOT), design of experiment (DOE), validation, transfer and pilot production. Customers will be able to access plug-and-play space for validation with injection molding machines ranging from 50-300 metric tons. Work is expected to start on phase two in May and be completed in October.

“Building on Winther Mould’s rich history as a premier healthcare tooling manufacturer while transforming into a state-of-the-art facility has been an exciting endeavor,” said Ken Hansen, production director at MGS Lynge. We are proud to be part of MGS’ continued efforts to be a world-class healthcare manufacturer from upfront product design and development through final production.”    

To learn more about MGS Lynge, visit our website.  

About MGS

Headquartered in Germantown, Wisconsin, USA, MGS is a leading end-to-end solutions provider bridging the gap between imagination and realization for healthcare innovators. For leading Pharmaceutical, Diagnostic and MedTech companies, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities – from design to full assembly – combined with the strong customer focus and seamless collaboration of an agile partner. Customers can access these capabilities from any of the company’s 12 global locations. Learn more at .

Product Development & Design, Tooling, and Automation Teams Offer Unmatched Depth & Experience

GERMANTOWN, Wisc. (January 31, 2024) – is pleased to announce the launch of its Global Engineering Services Group which brings together more than 85 engineers and 200 toolmakers globally, enabling Pharma, Diagnostic and MedTech innovators to quickly take healthcare projects from napkin sketch to validated product, process, and production cell setup. This follows on the heels of planned strategic acquisitions to increase the company’s front-end engineering skills and global capacity across North America and Europe.

According to Paul Manley, MGS President & CEO, “Our Global Engineering Services Group is a critical link in meeting growing demand from leading healthcare companies for holistic manufacturing solutions from concept through delivery. We know from our roots in toolmaking that world-class manufacturing is dependent on early product development and design that supports innovative tooling and automation solutions with early insights into the production process.”

Product development and design engineers draw on competencies in R&D, regulatory compliance, quality, and project management to achieve faster time-to-market and significantly reduced risk with a seamless transition to tooling. Setting the benchmark in technology and moldmaking innovations, MGS’ global tooling team successfully delivers hundreds of precision injection molds each year with capacity to quickly scale large programs.

The company’s global tooling capacity expanded to more than 200 toolmakers through recent acquisitions in Europe. In Europe alone, more than 120 skilled toolmakers and mold designers in Ireland, Denmark, Sweden, Germany, and Belgium give customers local and regional access to MGS’ unmatched tooling capacity. Tools and molding processes are validated in dedicated centers in Denmark and the U.S where ISO 13485-certified environments offer “plug and play” space for customer injection molding machines and automation setup.

A unique area of expertise and craftsmanship for MGS, custom automation technologies leverage decades of manufacturing experience to create and design scalable automation solutions that drive robust and quality-controlled manufacturing processes to deliver and maximize ROI. End-of-arm tooling (EOAT), proof-of-concept, press-side, decoupled indexing, and continuous motion systems round out MGS’ full scope of automation solutions.

“The success of our Engineering Services Group is really measured in our ability to manufacture the highly critical, high-precision products that leading Pharma, Diagnostic and MedTech companies count on to gain a competitive advantage,” Manley said. “This means driving manufacturing productivity, repeatability, and cost savings. We can only achieve that manufacturing goal when product design, tooling and automation set us up to accomplish it. That’s why I’m so excited to see the impact that this new global engineering services group will have on customer outcomes.”

To learn more about MGS’ Engineering Services Group, visit /engineering/.

About MGS

Headquartered in Germantown, Wisconsin, USA, MGS is a leading end-to-end solutions provider bridging the gap between imagination and realization for healthcare innovators. For leading Pharmaceutical, Diagnostic and MedTech companies, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities – from design to full assembly – combined with the strong customer focus and seamless collaboration of an agile partner. Customers can access these capabilities from any of the company’s 12 global locations. Learn more at .

Expanded Global Footprint and Capabilities Bridge the Gap Between Imagination & Realization for Healthcare Innovators Worldwide

GERMANTOWN, Wisc. (November 21, 2023) – , best known for its rich history as a leading manufacturer of complex tooling, automation technologies and high-precision plastic components, has taken a bold move forward in the positioning of its new brand. Focused solely on the healthcare industry, the brand elevates MGS’ status as a single-source solutions provider to leading Pharmaceutical, Diagnostic and MedTech companies worldwide.

The brand launch follows strategic acquisitions of leading European toolmaker Formteknik, Danish Product Development & Design firm Technolution, and Winther Mould Technology, a Danish healthcare tooling manufacturer. Coupled with enhancements to its state-of-the-art advanced manufacturing operations in Ireland, Mexico and the United States, MGS can now deliver more high-volume, highly complex healthcare programs globally with greater speed than ever before.

“Our new mission is to leverage our expertise and vertically integrated capabilities to transform our customers’ most pressing challenges into innovations that improve lives,” said Paul Manley, MGS President & CEO. “For our customers, this means access to robust capabilities – from product design to full assembly – combined with the strong customer focus and seamless collaboration of an agile partner. For our employees, this means we can make a meaningful difference in peoples’ lives in the work we do every day.”

In North America, MGS is building on the entrepreneurial spirit and history of innovations that have long been a hallmark of the company. A new 120,000-square-foot Innovation Center at its headquarters campus in Germantown, Wisc. will leverage collaborative workspaces, Class 7 & 8 cleanrooms and a dedicated quality lab to deliver early product development innovations from a single location – without disruption to its manufacturing environments. This space for upfront development gives customers the ability to move with speed and precision to meet demanding timelines. MGS also continues to evaluate opportunities to serve customers in new locations – including the exploration of a new facility in Costa Rica.

“I’ve had the privilege of being part of MGS for more than 25 years and have experienced first-hand the breakthrough innovations that define this company. MGS’ new brand announces that we’re going to keep this momentum going – not just in our manufacturing and product innovations, but in the innovative ways customers can access our unique expertise and end-to-end solutions from every MGS location. That’s the future we’re producing. That’s the future healthcare innovators need to bridge the gap between imagination and realization,” Manley concluded.

For more information about MGS’ new brand, visit our website .

About MGS

Headquartered in Germantown, Wisconsin, USA, MGS is a leading end-to-end solutions provider bridging the gap between imagination and realization for healthcare innovators. For leading Pharmaceutical, Diagnostics and MedTech companies, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities – from design to full assembly – combined with the strong customer focus and seamless collaboration of an agile partner. Customers can access these capabilities from any of the company’s 12 global locations. Learn more at .

GERMANTOWN, Wis. (October 3, 2023) – MGS announced today that it ranked No. 69 on Deloitte’s , a ranking of the 75 largest private companies in Wisconsin, based on sales revenue.

MGS president & chief executive officer, Paul Manley, credits the company’s continued growth as an end-to-end manufacturing partner for global Pharma, MedTech and Diagnostic companies, as well as MGS’ recent acquisitions with the company’s accomplishment. He said, “We continue to grow our manufacturing footprint here in Wisconsin, and around the globe, to meet growing customer needs across healthcare markets. This allows us to accelerate speed-to-market and ensure quality of innovative solutions that improve lives.”

“As we celebrate the achievements of these 75 enterprises, we are reminded of the driving force they represent in fueling economic growth and contributing to the vibrant tapestry of our state. Deloitte is proud to recognize the economic impact of these 75 private companies in Wisconsin —the Wisconsin 75. This year we will not only celebrate the individual successes of each of these organizations, but also the collective impact of private companies in powering Wisconsin’s economy.” said P.J. DiStefano, Wisconsin managing partner of Deloitte LLP.

MGS previously ranked No. 58 on the Wisconsin 75 list and has been featured on the list four times.

About Deloitte’s 2023 Wisconsin 75

Deloitte’s annual Wisconsin 75 list salutes the largest privately held Wisconsin-based companies. These companies play a key role in the state’s economy. Wisconsin 75 award winners are selected based on annual sales revenue.

To be eligible for Deloitte’s Wisconsin 75 recognition, companies must have a majority ownership by an individual(s), family, employee stock ownership plan, or private equity firm. Public companies are eligible when greater than 50 percent of the value or vote of the shares are owned by individuals, family, an employee stock ownership plan, or private equity. Additionally, companies must have annual sales revenue of at least USD 50,000. The Wisconsin 75 excludes cooperatives and accounting, tax, legal, and consulting service companies.

About MGS

Headquartered in Germantown, Wisconsin, USA, MGS currently operates from its 17 locations around the world. Recognized leaders in precision plastics, MGS offers vertically integrated global solutions across product design and development, tooling, automation and manufacturing. As a single-source manufacturing partner, MGS supports leading innovators in Pharma, Diagnostics and MedTech. Learn more about MGS at www.mgsmfg.com.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see to learn more about our global network of member firms.

GERMANTOWN, Wis. (October 2, 2023) – MGS, a global leader in end-to-end manufacturing solutions for healthcare innovators, announced today the acquisition of healthcare tooling manufacturer, Winther Mould Technology A/S (“Winther Mould”). The investment in additional tooling capacity and expertise reinforces MGS’ offer of best-in-class speed-to-market and continues the company’s strategic growth as a leading provider of high-precision plastic solutions for Pharma, Diagnostic and MedTech applications.

Located in Demark, Winther Mould brings 56 years of experience in design for manufacturing (DFM), mold design and manufacturing, and testing and validation to supplement MGS’ proven track record in launching and maintaining large-scale healthcare programs. In partnering with Winther Mould, MGS will add complex, premium-quality tooling and moldmaking capacity and expertise to its international network of tooling, automation and manufacturing capabilities. Both companies offer decades of experience in meeting the needs of leading healthcare customers.

“We celebrate this new growth milestone for MGS, which further strengthens our offer of unparalleled tooling capacity to ensure the seamless launch of large-scale programs. Our expanding global footprint continues to provide healthcare innovators with end-to-end support for new product introductions and ongoing production,” said Paul Manley, president and CEO of MGS. “MGS and Winther Mould share a strong customer focus and commitment to agility and reliability. Together, we are poised to deliver unmatched value, precision and dedication to our global customers to accelerate the development of innovations that improve lives.”

Kenneth Winther, general manager of Winther Mould, expressed enthusiasm about the partnership, saying, “With MGS, we are joining a team that will take our business to the next level. We are excited to grow with an end-to-end global solutions provider to offer customers a comprehensive solution from initial concept to high-volume manufacturing and commercialization.”

MGS is expanding global access to vertically integrated solutions, now with 1,200 employees at 12 locations across the United States, Mexico, Ireland, Denmark, Sweden and Germany. Recently acquiring Denmark-based product development and design firm, Technolution, MGS is evolving its unique position in the industry’s value chain with single-source engineering and manufacturing services.

For more information about MGS, visit mgsmfg.com. For more information about Winther Mould, visit .

About MGS

Headquartered in Germantown, Wisconsin, USA, MGS currently operates from its 12 locations around the world. Recognized leaders in precision plastics, MGS offers vertically integrated global solutions across product design and development, tooling, manufacturing, and automation. As a single-source manufacturing partner, MGS supports leading innovators in Pharma, Diagnostics and MedTech. Learn more about MGS at www.mgsmfg.com.

About Winther Mould Technology A/S

Winther Mould Technology A/S, located in Lynge, Denmark, is a highly specialized mold technology manufacturer renowned for producing superior quality molds for premium quality molded components. With 56 years of tooling experience, Winther Mould Technology excels in design for manufacturing (DFM), component design, moldmaking, testing and validation.

GERMANTOWN, Wis. (September 20, 2023) – MGS, a global leader in end-to-end manufacturing solutions for healthcare innovators, recently broke ground on a new state-of-the-art Innovation Center on the company’s Germantown, Wisconsin campus. The expansion, which brings an additional 120,000-square-feet to MGS’ headquarters, represents the company’s ongoing investments in growth and expansion to meet customer needs in Pharma, Diagnostics and MedTech.

The MGS Innovation Center, which is expected to be open to customers by the end of 2024, will feature collaborative workspaces dedicated to ideation and product development, tooling development, automation, and part and process validation. Also on-site will be Class 7 and 8 cleanroom space for part and process validation without disruption to production environments. An on-site dedicated Quality Lab with enhanced tactile-, optical- and CT-measuring capabilities will ensure optical, dimensional and functional product quality throughout the product development process.

“The MGS Innovation Center represents an important milestone in our ongoing investment in supporting our growing customer base with end-to-end solutions from product development through delivery,” said Paul Manley, CEO.

The Innovation Center also consolidates MGS’ existing Germantown Global Automation Center and Menomonee Falls, Wisconsin Sampling Facility onto a single campus, integrating them with MGS’ newly acquired product development and design capabilities. Customers will be able to access all aspects of early product development on a single campus for greater access and efficiency.

“We look forward to bringing our early product development solutions together within our Wisconsin campus to help our customers bridge the gap between imagination and realization,” continued Manley. “Together, we will uncover solutions to drive innovations that improve lives.”

MGS is partnering with Nashotah, Wis.-based MSI General for the construction.

About MGS

Headquartered in Germantown, Wisconsin, USA, MGS currently operates from its 16 locations around the world. Recognized leaders in precision plastics, MGS offers vertically integrated global solutions across product design and development, tooling, manufacturing and automation. As a single-source manufacturing partner, MGS supports leading innovators in Pharma, Diagnostics and MedTech. Learn more about MGS at www.mgsmfg.com.

GERMANTOWN, WI (June 6, 2023) – 91�첥. Group, Inc. (MGS), a global provider of integrated manufacturing solutions for complex, high-precision plastic components for Healthcare and Pharma applications, announced today that it has acquired Denmark-based Technolution A/S (Technolution), a fast-growing consultancy and development company within Pharma and MedTech. This partnership establishes a position unique in the industry’s value chain—providing a seamless, vertically integrated solution from initial design ideation to final product delivery.

The acquisition brings together Technolution’s proven expertise in R&D, regulatory compliance, quality, and project management with MGS’ proven expertise in tooling, molding and automation for high-quality Drug Delivery Devices, Diagnostics and more. By combining forces, Technolution and MGS mitigate project risks for their clients, and create an approach that streamlines the supply chain and accelerates time-to-market.

“Extending our offerings into the early stages of product development takes us to the next level of medical contract manufacturing,” said MGS CEO Paul Manley. “And like Technolution, we achieve our goals with the most important factor, our employees, and nurture a culture of pioneering spirit, enthusiasm and a will to succeed.”

Commenting on the new partnership, Technolution founder and primary shareholder Allan Spork said, “We’re very excited by this opportunity for our company. MGS has already acquired Formteknik, a provider of valuable services from the DFM/ESI to the validated upscale turn-key solution, with whom we have been working closely for more than a decade. Bringing us all together makes our offering uniquely comprehensive.”

For Technolution CEO Thomas Bach Agerslev, the partnership opens new prospects for the company and its stakeholders. “Having multiple providers is inefficient and costly for Pharma and MedTech companies. That’s why they increasingly demand end-to-end solutions from a single supplier such as Technolution and MGS. For customers, this means a more integrated process, smoother collaboration through all phases, and as a result, faster time-to-market.”

To learn more about MGS, visit www.mgsmfg.com. To learn more about Technolution, visit .

About MGS

Headquartered in Germantown, Wisconsin, USA, 91�첥. Group. Inc. currently operates from its 16 locations around the world. Acknowledged specialists in precision plastics, MGS offers vertically integrated total solutions across tooling, molding and automation from a single source, providing exceptional value to its global clients in Pharma, Diagnostics and Healthcare.

About Technolution

Technolution is based in Hørsholm, North of Copenhagen, Denmark. The company, a market leader in its field, currently employs 77 across multiple disciplines, and has to date handled 240-plus projects for start-ups over the past twenty years. During that time, Technolution has gained a reputation as expert in transforming ideas into innovative healthcare solutions.

GERMANTOWN, WI (October 27, 2022) – Titan CEO and headline sponsor Wipfli LLP are pleased to announce Paul Manley, President and CEO of 91�첥. Group as a 2023 Wisconsin Titan 100. The Titan 100 program recognizes Wisconsin’s Top 100 CEOs & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating exceptional leadership, vision, and passion. Collectively the 2023 Wisconsin Titan 100 and their companies employ more than 100,000 individuals and generate $36 billion dollars in annual revenues. This year’s honorees will be published in a limited-edition Titan 100 book and profiled exclusively online. They will be honored at the annual awards ceremony on January 12th, 2023 at Fiserv Forum, and will be given the opportunity to interact and connect multiple times throughout the year with their fellow Titans.

“The Titan 100 are shaping the future of the Wisconsin business community by building a distinguished reputation that is unrivaled and preeminent in their field. We proudly recognize the Titan 100 for their successes and contributions. We know that they will have a profound impact that makes an extraordinary difference for their customers and clients across the nation.” says Jaime Zawmon, President of Titan CEO.

Manley joined MGS more than 25 years ago, working in a number of roles in the company before becoming President in 2016 and CEO in 2019. He has been instrumental in building MGS to be one of the top global plastics contract manufacturers in the healthcare industry. The company was recently named to Deloitte’s 2022 Wisconsin 75 list and was named a finalist in the 2022 Wisconsin Manufacturer of the Year Awards. These recognitions are a testament to Manley and a talented leadership team driving significant growth across MGS.

“I am honored to be recognized by the Titan 100 program alongside many other talented Wisconsin executives who are advancing our economy and driving growth,” said Manley. “This recognition is only possible with the hard work and dedication of the global MGS team that works every day to innovate new solutions to complex problems for critical products and technologies in the healthcare industry.”

Manley will be honored at the annual Titan 100 awards celebration on January 12, 2023 at Fiserv Forum, home of the Milwaukee Bucks. This unique cocktail-style awards event will gather 100 Titans of Industry and their guests for an evening unlike anything that exists in the Wisconsin business community.

“On behalf of all the partners and associates at Wipfli we congratulate all the Titan 100 winners. It’s an honor to recognize this diverse group of leaders in Wisconsin. We appreciate the lasting impact each leader has made, and continues to make, in building organizations of significance both here in Wisconsin and abroad. Your ingenuity and creativity have set you apart, and the honor of being seen as an industry Titan is richly deserved,” says Gina Skibo, Partner at Wipfli.

Vertically Integrated Capabilities to Drive Healthcare Manufacturer Success Worldwide

GERMANTOWN, WI (August 4, 2021) – With an accelerated focus on vertically integrating its tooling, molding and automation capabilities through cross-functional collaboration and a single source of accountability, MGS is positioned to do all it can to drive customer success in a healthcare market earmarked by complexity, uncertainty and speed. The company will be sharing more about its unique ability to drive this success at the upcoming MD&M West conference in Anaheim, CA (August 10-12). 

A contract manufacturing partner to more than 50 of the world’s leading healthcare and pharmaceutical providers, MGS has made several recent bold moves to help companies de-risk the supply chain, innovate more quickly and speed the delivery of complex components across the globe.

According to Paul Manley, MGS President & CEO, “Through the pandemic, our customers reaped the benefit of what we have known for a long time is MGS’ single greatest differentiation: the ability to integrate our capabilities to design, execute and ramp up production quickly. Producing millions of COVID-19 test kit components in just 12 weeks would not have been possible without tapping the experience and cross-functional expertise inside the company.”

To accelerate customer adoption of these competencies globally, the company has recently taken several steps to equip customers with the capabilities and experience they need. Visitors to MGS booth #3059 will gain insights into:

The recently formed iMGS business (integrated MGS) which provides customers with a single source of supply and accountability across its tooling, molding and automation businesses. The iMGS business is part of MGS’ Healthcare Center of Excellence located in Germantown, WI.

The acquisition of Formteknik, a European-based manufacturer of innovative tooling solutions with locations in Denmark, Sweden and Germany. Formteknik, in partnership with MGS Ireland, accelerates MGS’ ability to expand its vertically-integrated healthcare delivery model across Europe and other parts of the world.

The recently created position Chief Technology Officer & Senior Vice President of Automation, held by Shawn Krenke, who oversees the company’s iMGS and automation businesses. The new role is designed to accelerate innovation and the delivery of global technology-driven solutions.

MGS now employs more than 1,500 employees with 17 facilities globally.Both Paul Manley and Bob Bordignon, Senior Vice President of Global Sales, will be available at MDM West for interviews.

About MGS
As a proven single-source of manufacturing expertise and accountability – in tooling, molding, and automation equipment technology – MGS knows how to deliver custom, integrated solutions that drive business performance and growth. MGS controls more of the supply chain in-house, minimizing risk, maximizing resources, and delivering better performance at every phase of every job.

New role accelerates emphasis on cutting-edge technology solutions.

GERMANTOWN, WI (August 3, 2021) – Germantown, WI-headquartered 91�첥. Group, a global provider of integrated manufacturing solutions for complex, high-precision plastic components, is pleased to announce the promotion of Shawn Krenke to Chief Technology Officer and Senior Vice President of Automation. 

In this newly created senior leadership position, Krenke will be responsible for advancing the technology solutions critical to the success of the company’s customers across increasingly sophisticated, fast-changing markets. Emphasis will be on four primary areas:

Driving the development and integration of custom, cutting-edge technologies that automate the production of highly complex products, integrate manufacturing processes and drive greater efficiencies and performance.

Accelerating customer adoption of its recently formed iMGS business which vertically integrates its world class capabilities through cross-functional collaboration and centralized accountability.

Ongoing development of automated solutions that include multi-shot equipment – which the company pioneered – vision, inspection, assembly equipment and more.

Supporting the ongoing integration of iMGS and advanced technologies throughout MGS’ North American and European operations following the 2021 acquisition of Formteknik, an innovative tooling solutions provider.

According to Paul Manley, MGS president, “It is with great enthusiasm that we name Shawn to lead this increasingly important area of our business. His demonstrated ability to advance the development of technology and automation solutions has played an integral role in driving MGS’ growth. The knowledge and expertise he brings to this role will be invaluable to the company as we evolve our position as a leading global contract manufacturing partner.”

Krenke’s 22 years with MGS includes several automation and engineering leadership positions, most recently Vice President of the Automation Group, which he was instrumental in founding. This experience is coupled with hands-on development of a broad range of the company’s automation and technology solutions. Krenke began his career at MGS after graduating from Moraine Park Technical College.

According to Krenke, “As we look to the future, MGS has a tremendous opportunity to accelerate the utilization of technologies across our businesses, and to drive innovation and speed-to-market through the vertical integration of our tooling, molding and automation capabilities. I’m very excited about the advantages this brings to customers across markets and across the globe.”

About MGS
As a proven single-source of manufacturing expertise and accountability – in tooling, molding, and automation equipment technology – MGS knows how to deliver custom, integrated solutions that drive business performance and growth. MGS controls more of the supply chain in-house, minimizing risk, maximizing resources, and delivering better performance at every phase of every job.